Pay in 4 interest-free payments of $6.78 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
Because angiogenesis is a defining hallmark of tumor growth and metastatic progression, any therapeutic agent that enhances neovascularization could, in theory, facilitate tumor expansion and promote metastatic dissemination
Its important for users to follow the recommended usage instructions and to consult with a dermatologist to ensure safety and effectiveness, as some ingredients might cause skin irritation or other side effects when used improperly
Starting at: $139/mo (monthly flat all-inclusive)
Market Outlook Market Growth Overview: The U.S
It is classified as a research chemical, meaning: It cannot be legally marketed as a drug or supplement It is not recognized as "Generally Recognized as Safe" (GRAS) No New Drug Application (NDA) has been submitted It has not undergone the formal FDA approval process Research Chemical Status BPC-157 is available for purchase as a "research chemical" in most jurisdictions, with important caveats: Sold for "research purposes only" Not for human consumption (legally) No quality standards enforced by regulatory agencies Purity and identity depend entirely on supplier integrity International Regulations Regulatory status varies by country: United States : Research chemical, not approved for human use European Union : Not approved, status varies by member state Canada : Not approved for human use, research chemical Australia : Not approved, TGA Category 4 substance United Kingdom : Not approved for human use Sports and Competition BPC-157 is not specifically listed on the World Anti-Doping Agency (WADA) prohibited list, unlike TB-500
Short-Term Use Recommended: Typically used for 34 months, followed by a break to prevent ochronosis.
US$ 20.37
US$ 23.43
US$ 25.15
US$ 24.13
US$ 29.33
US$ 20.22
US$ 21.81
US$ 21.55
US$ 23.33
